Arkade Developers shares rise 2% after company announces Rs 2,000 crore Thane project
By Aditya Bhagchandani Published on June 16, 2025, 09:24 IST
Shares of Arkade Developers Ltd rose over 2% to ₹195.50 in Monday's early trade after the company announced a strategic land acquisition in Thane. The Mumbai-based real estate company confirmed its foray into the Thane market with a 6.28-acre freehold land parcel at Kasarvadavali, Ghodbunder Road.
The company disclosed that the transaction, valued at ₹172.48 crore including stamp duty, is intended for a marquee mixed-use development with a projected gross development value (GDV) of ₹2,000 crore. The project is expected to offer 2, 3, and 4 BHK residences alongside curated retail and commercial spaces, with launch slated for early 2026.
The site offers sweeping views of the Sanjay Gandhi National Park and benefits from strong infrastructure connectivity via Eastern Express Highway and the upcoming Metro Line 4 and Thane-Borivali twin tunnel.
Arkade Developers Chairman & MD Amit Jain noted that the Thane expansion marks a major milestone in the company's growth, adding to recent developments in Kanjurmarg, Mulund, and Bhandup. The company also highlighted its recent acquisition of the 4-acre Filmistan land parcel in Goregaon with an estimated GDV of ₹3,000 crore.
As of the latest update, Arkade Developers shares were trading at ₹195.50, up 2.25% from the previous close of ₹191.20.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
37 minutes ago
- Business Upturn
Why SKF India shares surge 4% today? Details here
SKF India shares rose over 4% in morning trade after the company announced a robust automotive capacity expansion plan worth ₹4,000–₹4,600 crore, to be implemented between FY25 and FY30. As of 10:47 AM, the shares were trading 3.58% higher at Rs 4,789.20. The planned investments will be spread across its key manufacturing hubs in Haridwar, Pune, and Bangalore, aimed at strengthening its position in both ICE (internal combustion engine) and EV (electric vehicle) segments. The Haridwar plant, focused on deep groove ball bearings (DGBB) for 2-wheelers and EV powertrains, will get a ₹1,000–1,500 crore investment to increase capacity by 50% by 2029. Pune will see the highest investment—₹3,000–3,500 crore by 2030—to scale up production of hub bearing units (HBU) and taper roller bearings (TRB) by 30%, serving passenger and commercial vehicles across ICE and EV platforms. The Bangalore facility will receive ₹100 crore for a 10% capacity hike by 2026, enhancing DGBB and cylindrical roller bearing (CRB) output. Additionally, SKF India has provided a strong earnings outlook. The company expects its industrial business EBITDA margin to remain in the 16–18% range, and automotive business EBITDA margin to stay between 17–19%, over the next three years. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Wire
an hour ago
- Business Wire
Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers
BASEL, Switzerland--(BUSINESS WIRE)--Syngenta is accelerating the rollout of its nature-inspired, science-based biological solutions, responding to rising demand for sustainable, high-performance tools that help farmers boost productivity efficiently and responsibly. It also contributes toward Syngenta's fulfilment of commitments outlined in its Sustainability Priorities. Jonathan Brown, Global Head Biologicals & Seedcare, comments: 'With our recent partnerships and acquisitions and extended manufacturing capacities, Syngenta is positioning itself as the leader in biologicals. Our scientific expertise is at the forefront of our research and development efforts to provide farmers with the next generation of biologicals, helping them transition towards more sustainable farming practices, such as regenerative agriculture.' In December 2024, the company acquired Intrinsyx Bio, a California-based start-up specializing in the development of nutrient-use efficiency products. Most recently, in early 2025, Syngenta concluded the integration of Novartis' Strains and Natural Products Collection, the repository of natural compounds and genetic strains for agricultural use. These additions will accelerate the development of biologicals, bringing new tools to the market as a sustainable complement to conventional crop protection solutions. Also in 2025, Syngenta opened a 22,000 m² biologicals facility in Orangeburg, South Carolina, in the United States, which is purpose-built to produce 16,000 tons of biostimulants annually. This new manufacturing facility complements Syngenta's existing global network of biologicals' manufacturing facilities in Brazil, Italy, India and Norway. These strategic milestones effectively enhance both Syngenta's R&D, operating out of the centers of excellence in Stein, Switzerland; Jealott's Hill, UK; Atessa, Italy; and production capacity for biologicals, facilitating Syngenta's roll out of its biologicals pipeline, with multiple candidates demonstrating strong commercial potential with projected annual sales above USD 100 million. Syngenta Biologicals posted strong Q1 2025 results, with standout performance in North America and China. The global biologicals market is growing at around 10% CAGR and is projected to reach nearly USD 20 billion by 2030, according to AgbioInvestor and Syngenta's estimate, underlining the pivotal role of biologicals in the future of sustainable farming. Derived predominantly from naturally occurring substances, biologicals offer significant potential for sustainable agriculture. The market can be categorized into three main categories: Biocontrols – Naturally derived products for managing pests, diseases, and weeds. Biostimulants – Products enhancing natural plant processes to improve abiotic stress tolerance and crop quality. Nutrient Use Efficiency (NUE) products – Any substance or microorganism to improve macro- and micronutrient availability and uptake to promote growth and enhance yield. About Syngenta Syngenta is a global leader in agricultural innovation with a presence in more than 90 countries. Syngenta is focused on developing technologies and farming practices that empower farmers, so they can make the transformation required to feed the world's population while preserving our planet. Its bold scientific discoveries deliver better benefits for farmers and society on a bigger scale than ever before. Guided by its Sustainability Priorities, Syngenta is developing new technologies and solutions that support farmers to grow healthier plants in healthier soil with a higher yield. Syngenta Crop Protection is headquartered in Basel, Switzerland; Syngenta Seeds is headquartered in the United States. Read our stories and follow us on LinkedIn, Instagram & X. Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ('legitimate interest'). However, if you do not wish to receive further information about Syngenta, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement. Cautionary Statement Regarding Forward-Looking Statements This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions, or other factors. ©2025 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland.
Business Insider
an hour ago
- Business Insider
Lululemon is accusing Costco of ripping off its chinos and yoga jackets
Lululemon is going after Costco, saying it copied the designs of some of its most popular product lines. The Vancouver-based athleisure brand filed a lawsuit against Costco on Friday in California court, accusing it of ripping off the designs of its yoga jackets and chinos. In the 49-page filing, it spotlighted three product lines — its Scuba hoodies and sweatshirts, Define jackets, and ABC pants — saying Costco had created "confusingly similar" dupes of them. It said Costco had infringed its "trade dress," a broad trademark law that protects the look and feel of a product. In the lawsuit, Lululemon put pictures of Costco's and its products side by side in tables to emphasize design similarities. For example, it compared Costco's Kirkland men's pants, priced at $19.90, to the $128 ABC men's pants. It also compared Costco's Spyder women's yoga jacket, which retails for $21.90, to the Lululemon Define jacket, which retails for $128. "There is even a hashtag 'LululemonDupes' on social media platforms such as TikTok that social media influencers use when promoting these copycat products," Lululemon said in the filing. "The Infringing Products create an improper association with Plaintiffs' authentic products." Per the filing, Lululemon said it wanted damages from Costco in the form of lost profits and compensation for patent infringement. It also wants Costco to stop manufacturing and selling more products that are "identical or confusingly similar" to Lululemon's clothing. Costco has yet to respond to Lululemon's lawsuit. Representatives for Lululemon and Costco did not respond to requests for comment from Business Insider. Lululemon has accused other companies of copyright infringement. In 2021, the brand sued exercise equipment company Peloton after it launched its clothing line. Lululemon used similar wording in that lawsuit, saying Peloton's products looked "confusingly similar" to its own Align leggings. The two companies settled the lawsuit in September 2022. In 2012, Lululemon sued Calvin Klein, saying the latter infringed design patents on its now-discontinued "Astro" yoga pants' signature waistband and design. However, it withdrew the lawsuit in the same year after the parties agreed to a confidential settlement.
